To test the functional consequence of this switch in pHGG and GBM, we blocked NF1 exon23a inclusion with morpholinos targeting the 3’ and 5’ intron–exon junctions to interfere with spliceosome access. This evidence concerns the gene NF1 and glioblastoma.